Amgen drug shrank tumors in patients with 'undruggable' cancer protein

Amgen drug shrank tumors in patients with 'undruggable' cancer protein

STAT Plus: Amgen’s drug — targeting an ‘undruggable’ cancer protein — shrank tumors in half of patients

By ADAM FEUERSTEIN

ADOBE

Discovering drugs capable of blocking KRAS has proven difficult. The protein is spherical and nearly featureless — like that of a tennis ball.

READ MORE